Ensitrelvir cuts household COVID-19 risk when given after exposure

A five-day course of ensitrelvir sharply reduced symptomatic COVID-19 in exposed household contacts, offering fresh evidence that targeted oral antivirals may help protect people soon after close exposure.
Read more...